(Q47809781)

5 February 2018

title

Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease. (English)

1 reference

5 February 2018

author name string

Noh GW

1

1 reference

5 February 2018

Lee WG

2

1 reference

5 February 2018

Lee W

3

1 reference

5 February 2018

Lee K

4

1 reference

5 February 2018

publication date

1 May 1998

1 reference

5 February 2018

published in

immunology Letters

1 reference

5 February 2018

volume

62

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

19-24

1 reference

5 February 2018

Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Kawasaki disease and Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Antibodies to native type III collagen in the serum of patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Increased serum interleukin-10 level in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

The short unique region of the B95-8 Epstein-Barr virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Immunoregulatory abnormalities in mucocutaneous lymph node syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

1 reference

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Cytokines and Ly-1 (B1) B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900016-9

7 January 2021

10.1016/S0165-2478(98)00016-9

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9672143

1 reference

5 February 2018